Argent Advisors, Inc. Vbi Vaccines Inc Transaction History

Argent Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$2.61 - $4.17 $28,532 - $45,586	-10,932 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$2.91 - $4.32 $31,812 - $47,226	10,932 New	10,932 $34,000
Q4 2020 Feb 11, 2021	SELL	$2.15 - $3.5 $23,503 - $38,262	-10,932 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$2.77 - $6.17 $30,281 - $67,450	10,932 New	10,932 $31,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Argent Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Argent Advisors, Inc. with notifications on news.